Clinical Trial Update: Menstrual Blood-Derived Mesenchymal Stem Cell Injection (SC01009) in the Treatment of Idiopathic Pulmonary Fibrosis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating SC01009 menstrual blood-derived mesenchymal stem cell injections for idiopathic pulmonary fibrosis, currently not yet r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Pulmonary Fibrosis

Drugs mentioned

• SC01009 menstrual blood-derived mesenchymal stem cell injection

Snippet

Sponsor: Ruijin Hospital | Conditions: Idiopathic Pulmonary Fibrosis (IPF) | Phase 2 | Status: NOT_YET_RECRUITING